SCHEMBL6906495

SCHEMBL6906495

CC(C)c1cccc(C(C)C)c1/N=C/c1cccc(/C=N/c2c(C(C)C)cccc2C(C)C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.38
LMNA P02545 3/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRB2 P47870 2/20 0.38
FAAH O00519 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
HTR2B P41595 1/20 0.38
GABRA2 P47869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687037 1.00 GABRA1 (0.38) GABRA1LMNAGABRG2GABRB3GABRB2
SCHEMBL5587893 0.98 GABRA1 (0.36) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7179141 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7176289 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL1685836 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7184104 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7177018 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7182511 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
Hydrochloric Acid SCHEMBL7181846 0.96 GABRA1 (0.35) GABRA1LMNAGABRG2GABRB3GABRB2
SCHEMBL7089893 0.92 LMNA (0.32) GABRA1LMNAGABRG2GABRB3GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695260-B2 Method for producing olefin block polymer using plurality of types of transition metal catalysts SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-04 US disclosed
US-9695260-B2 Method for producing olefin block polymer using plurality of types of transition metal catalysts SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-04 US disclosed
US-20150224490-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING (US) 2015-08-13 US disclosed
US-20150224490-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING (US) 2015-08-13 US disclosed
US-20140275429-A1 METHOD FOR PRODUCING OLEFIN BLOCK POLYMER USING PLURALITY OF TYPES OF TRANSITION METAL CATALYSTS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-09-18 US disclosed
US-20140228570-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING CORPORATION 2014-08-14 US disclosed
US-20140228570-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING CORPORATION 2014-08-14 US disclosed
WO-2013043846-A1 METAL CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2013-03-28 WO disclosed
US-20080021180-A1 CHROMIUM CATALYSTS ACTIVE IN OLEFIN POLYMERIZATION REPSOL QUIMICA, S.A. 2008-01-24 US disclosed
WO-2004074333-A2 PROCESS FOR HOMO- OR COPOLYMERIZATIONOF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES INC. (US) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150224490-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts HIRA, TPR, TST GABRA1 1885/4885LMNA 1734/4885GABRG2 2347/4885
US-20140228570-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts HIRA, TPR, TST GABRA1 1885/4885LMNA 1734/4885GABRG2 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.